Author: Dorron Blumberg

image_pdfimage_print

Paying tribute for 365 days of COVID-19 and still on the frontline of the pandemic

March 18, 2021 –  Marking the one-year anniversary of the hospitalization of the first COVID-19 patient at Palms West Hospital, Mayor Lisa Al-Ramey of Loxahatchee, FL, delivered a proclamation designating March 12 as Palms West Hospital Worker Appreciation Day. The proclamation recognizes doctors, nurse, and all support staff at Palms West Hospital, for their vital role in caring for the community throughout the pandemic.

Read More

Our Fund Foundation Grant Helps the Diversity Unity Coalition to Combat Vaccine Hesitancy in the LGBTQ Community

March 17, 2021 – When Our Fund Foundation, South Florida’s only LGBTQ community foundation, learned of the Humanity Project’s newly formed Diversity Unity Coalition’s effort to combat Covid-19 vaccine hesitancy within underrepresented communities, Our Fund pledged monies from its discretionary fund to support the grassroots initiative.

Read More

MEMORIAL CANCER INSTITUTE TOGETHER WITH FLORIDA ATLANTIC UNIVERSITY RESEARCH PARTNERSHIP EARN "CANCER CENTER OF EXCELLENCE"; DESIGNATION

March 18 2021 – A research partnership formed just last year by Memorial Healthcare System and Florida Atlantic University is already being recognized for quality care, results, and advances in research, and that’s great news for patients fighting cancer in South Florida. The alliance between Memorial’s Cancer Institute and FAU (MCIFAU) has been recognized by the state’s Department of Health as a “Florida Cancer Center of Excellence.”

Read More

M2GEN Announces New Collaboration with Merck to Advance Cancer Therapies

Merck Secures 5-year Access to Data Supporting Oncology Research
 
March 17, 2021 – M2GEN, a leading oncology-focused data and informatics company, announced today a significant new five-year agreement with Merck, known as MSD outside the United States and Canada. Under the terms of the agreement, M2GEN will provide valuable patient-consented, de-identified, linked clinical and genomic data in support of Merck’s oncology efforts.
 

Read More